The Health Effects of Low-Dose Radiation on Atomic Workers

1980 ◽  
Vol 10 (1) ◽  
pp. 37-46 ◽  
Author(s):  
Theodor D. Sterling

The 15-year history of a study on the health effects of low-dose radiation on workers at the Hanford Atomic Plant in Washington State demonstrates different facets of political control by employers over investigations of employee working conditions. Evidence obtained through the Freedom of Information Act shows that the original study, under the guidance of Dr. Thomas Mancuso, an experienced and respected occupational health epidemiologist, was funded even though its design was thought to be inadequate in order to furnish proof to employees that their exposure levels were safe. When it turned out that the study might show an increase in cancer rates among plant employees, its control was transferred to the employer. Public reports by scientists working for the employer are at variance with independent analyses of the same data. Lessons from these events are that it may be necessary for organized labor to negotiate the conduct of occupational health investigations as part of negotiated settlements and for legal means to be developed to make health scientists accountable for actions that influence public health policies.

2018 ◽  
Vol 58 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Andrzej Wojcik ◽  
Karim Hamza ◽  
Iann Lundegård ◽  
Margareta Enghag ◽  
Karin Haglund ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 2212
Author(s):  
Jihang Yu ◽  
Edouard I. Azzam ◽  
Ashok B. Jadhav ◽  
Yi Wang

The year 2020 will be carved in the history books—with the proliferation of COVID-19 over the globe and with frontline health workers and basic scientists worldwide diligently fighting to alleviate life-threatening symptoms and curb the spread of the disease. Behind the shocking prevalence of death are countless families who lost loved ones. To these families and to humanity as a whole, the tallies are not irrelevant digits, but a motivation to develop effective strategies to save lives. However, at the onset of the pandemic, not many therapeutic choices were available besides supportive oxygen, anti-inflammatory dexamethasone, and antiviral remdesivir. Low-dose radiation (LDR), at a much lower dosage than applied in cancer treatment, re-emerged after a 75-year silence in its use in unresolved pneumonia, as a scientific interest with surprising effects in soothing the cytokine storm and other symptoms in severe COVID-19 patients. Here, we review the epidemiology, symptoms, immunological alterations, mutations, pharmaceuticals, and vaccine development of COVID-19, summarizing the history of X-ray irradiation in non-COVID diseases (especially pneumonia) and the currently registered clinical trials that apply LDR in treating COVID-19 patients. We discuss concerns, advantages, and disadvantages of LDR treatment and potential avenues that may provide empirical evidence supporting its potential use in defending against the pandemic.


2016 ◽  
Vol 31 (Suppl 1) ◽  
pp. S10 ◽  
Author(s):  
Ki Moon Seong ◽  
Songwon Seo ◽  
Dalnim Lee ◽  
Min-Jeong Kim ◽  
Seung-Sook Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document